Innovative Trial Designs Reshape the U.S. Neurology Clinical Trials Market
The U.S. neurology clinical trials market, valued at USD 3.19 billion in 2024, is poised to expand at a compound annual growth rate (CAGR) of 6.7% between 2025 and 2034, reflecting both the increasing prevalence of neurological disorders and the rising complexity of therapeutic interventions in the sector. While the U.S. remains the dominant revenue generator due to advanced research...
0 Comments 0 Shares 541 Views 0 Reviews